Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial.
Chew EY, Clemons TE, Peto T, Sallo FB, Ingerman A, Tao W, Singerman L, Schwartz SD, Peachey NS, Bird AC; MacTel-CNTF Research Group.
Chew EY, et al. Among authors: schwartz sd.
Am J Ophthalmol. 2015 Apr;159(4):659-666.e1. doi: 10.1016/j.ajo.2014.12.013. Epub 2014 Dec 19.
Am J Ophthalmol. 2015.
PMID: 25528956
Free PMC article.
Clinical Trial.